相关实验视频

Updated: May 9, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

冠状动脉疾病和跨导管大动脉置换

Richard Tanner^1,2, Sean Gilhooley¹, David Power¹

¹Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York.

Journal of the Society for Cardiovascular Angiography & Interventions

|May 1, 2025

概括

患有严重的大动脉狭窄 (AS) 和冠状动脉疾病 (CAD) 的患者接受过导管大动脉置换 (TAVR) 需要仔细考虑冠状动脉干预时间和计划未来接入. 最佳的策略是为了改善临床结果,平衡风险和益处.

科学领域:

心脏病学心脏病学
干预心脏病学干预心脏病学
心脏外科手术心脏外科手术

背景情况:

同时严重的大动脉狭窄 (AS) 和冠状动脉疾病 (CAD) 常见于被考虑进行跨导管大动脉置换 (TAVR) 的患者.
侵袭性冠状动脉血管学是CAD评估的标准,冠状动脉CT血管学对低风险患者有用.
冠状动脉病变的功能评估在AS中是安全的,但它对结果的影响需要进一步研究.

研究的目的:

审查当前对TAVR候选人的同时发生的CAD和AS管理的理解.
讨论与TAVR相关的穿皮冠状动脉干预 (PCI) 的最佳时间和技术.
为了突出考虑未来的冠状动脉接入TAVR后.

主要方法:

对TAVR患者的CAD管理现有文献的综述.
对在AS的存在下进行功能测试的数据分析.
评估与TAVR后的复血管化时间和PCI策略相关的结果.

主要成果:

显著的CAD (≥90%的狭窄,FFR ≤0.80) 的血管再循环改善了与医疗治疗相比的结果.
在TAVR之前进行重血管化没有明确的好处;最佳时间仍然不确定.
短框架门在TAVR后促进了更好的冠状动脉接入,这对于计划或未来的PCI至关重要.

结论:

仔细规划PCI,考虑门类型和未来的接入,对于TAVR患有CAD的患者至关重要.
由于TAVR在年轻患者中日益流行,以及推迟的再血管化,可能会增加TAVR后的PCI手术.
需要个性化策略来优化AS和CAD组合的管理.

关键词:

大动脉狭窄症 (大动脉狭窄)冠状动脉疾病是一种冠状动脉疾病.重新血管化的过程.通过导管更换大动脉门.

更多相关视频

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation

Published on: June 3, 2018

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

相关概念视频

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...